Anal Chem March 2025 PMID 39967556

A Robust and Automated Platform for Charge Detection Mass Spectrometry of Megadalton Biotherapeutics.

Samuel E Janisse, Ryan T Fellers, Shannon A Raab, Michael P Goodwin, Kyle P Bowen, Zhirui J Lian, Kenneth R Durbin, Michael W Senko, Philip D Compton, Jared O Kafader, Neil L Kelleher

Mentions

4
Peak: 2 in Feb 2025
across 2 sources since Feb 2025

Extended reach

133
potential audience

Total likes

8

Video views

128

Mentions per month

Feb 2025 – Mar 2025

Where it's discussed

  • Bluesky3 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions emphasize the significance of the publication through enthusiastic language like 'Gene Therapy QC just got an upgrade' and highlight specific tools such as the SampleStream system and mass spectrometry, demonstrating both audience interest and understanding of its potential impact on biotherapeutic analysis.

AgreementModerate agreement

Most discussions recognize the publication as a significant advancement in gene therapy quality control, indicating general agreement on its importance.

InterestHigh interest

The enthusiasm in phrases like 'Gene Therapy QC just got an upgrade!' and 'Get key data in minutes' shows high interest from readers.

EngagementModerate engagement

Posts reference specific technical tools such as SampleStream and charge detection mass spectrometry, indicating a reasonable depth of engagement.

ImpactHigh impact

Several discussions highlight the potential for rapid and improved analysis methods to revolutionize quality control in biotherapeutics, emphasizing high impact.

Abstract in brief

  • Gene therapies using adeno-associated viruses (AAV) hold great promise for enhancing human health, but current quality control methods are inadequate.
  • A novel system combining an automated microfluidic device (SampleStream) with advanced mass spectrometry (SS-CDMS) allows for quick and efficient analysis of AAV samples in under 15 minutes, operating autonomously.
  • This SS-CDMS method can assess essential quality control attributes with minimal sample use and has the potential for application at multiple stages of AAV production, even in complex environments like cell culture media.

Top posts

Most liked on X and Bluesky
Kermit Murray
@kkmurray.bsky.social · Bluesky

(ACS Anal Chem) [ASAP] A Robust and Automated Platform for Charge Detection Mass Spectrometry of Megadalton Biotherapeutics: Analytical ChemistryDOI: 10.1021/acs.analchem.4c06397 http://dlvr.it/TJ4WGz #MassSpecRSS #ACSAChem

Feb 19, 2025 · 3 likes · 1 share View post →
BioMassSpec
@realbiomassspec.bsky.social · Bluesky

A Robust and Automated Platform for Charge Detection Mass Spectrometry of Megadalton Biotherapeutics #AC pubs.acs.org/doi/10.1021/...

Feb 19, 2025 · 3 likes · 2 shares View post →

All mentions

PAL System
@pal-system.bsky.social · Bluesky

Gene Therapy QC just got an upgrade! New research automates AAV analysis w/ PAL System-based SampleStream & CDMS. Get key data (MW, ratio) in minutes. See it in Anal. Chem.  https://pubs.acs.org/doi/10.1021/acs.analchem.4c06397  #TeamMassSpec #genetherapy

Mar 26, 2025 View post →
Kermit Murray
@kkmurray.bsky.social · Bluesky

(ACS Anal Chem) [ASAP] A Robust and Automated Platform for Charge Detection Mass Spectrometry of Megadalton Biotherapeutics: Analytical ChemistryDOI: 10.1021/acs.analchem.4c06397 http://dlvr.it/TJ4WGz #MassSpecRSS #ACSAChem

Feb 19, 2025 · 3 likes · 1 share View post →
BioMassSpec
@realbiomassspec.bsky.social · Bluesky

A Robust and Automated Platform for Charge Detection Mass Spectrometry of Megadalton Biotherapeutics #AC pubs.acs.org/doi/10.1021/...

Feb 19, 2025 · 3 likes · 2 shares View post →